"MIP Pharma Latvija" SIAActive
Key figures
Ratios
2025Balance sheet structure
Summary of financial statements2012–2025
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||||
| Total current assets | 14 920 | 16 702 | 10 694 | 3715 | 4209 | 3356 | 1786 | 1324 | 2594 | 1713 | 36 811 | 27 928 | 17 225 | 14 430 |
| Total non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 14 920 | 16 702 | 10 694 | 3715 | 4209 | 3356 | 1786 | 1324 | 2594 | 1713 | 36 811 | 27 928 | 17 225 | 14 430 |
| Balance sheet — liabilities and equity | ||||||||||||||
| Current liabilities | 132 366 | 198 584 | 208 700 | 218 441 | 236 000 | 255 097 | 267 091 | 272 374 | 280 761 | 280 026 | 302 180 | 275 188 | 243 913 | 244 383 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 132 366 | 198 584 | 208 700 | 218 441 | 236 000 | 255 097 | 267 091 | 272 374 | 280 761 | 280 026 | 302 180 | 275 188 | 243 913 | 244 383 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -10 287 | -14 772 | -16 106 | -16 720 | -17 065 | -19 950 | -13 564 | -5745 | -7117 | -146 | 12 944 | 18 109 | 20 572 | -3265 |
| Total equity | -117 446 | -181 882 | -198 006 | -214 726 | -231 791 | -251 741 | -265 305 | -271 050 | -278 167 | -278 313 | -265 369 | -247 260 | -226 688 | -229 953 |
| Income statement | ||||||||||||||
| Sales revenue | 652 | 964 | 757 | 619 | 1005 | 2833 | 9319 | 15 957 | 19 335 | 25 812 | 38 226 | 44 423 | 41 639 | 29 079 |
| Operating profit | -4910 | -5499 | -6237 | -6221 | -5970 | -6364 | 2376 | 10 861 | 9869 | 17 270 | 30 490 | 37 002 | 34 085 | 8270 |
| EBITDA | -4779 | -5499 | -6237 | -6221 | -5970 | -6364 | 2376 | 10 861 | 9869 | 17 270 | 30 490 | 37 002 | 34 085 | 8270 |
| Profit before income tax | -10 287 | -14 772 | -16 056 | -16 670 | -17 015 | -18 352 | -10 376 | -2427 | -3720 | 3324 | 16 453 | 21 888 | 23 275 | -984 |
| Profit for the reporting year | -10 287 | -14 772 | -16 106 | -16 720 | -17 065 | -19 950 | -13 564 | -5745 | -7117 | -146 | 12 944 | 18 109 | 20 572 | -3265 |
| Labour costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation of non-current assets | 131 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other indicators | ||||||||||||||
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Calculated dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Summary: "MIP Pharma Latvija" SIA
Overview
"MIP Pharma Latvija" SIA (reg. no. 40103290945) is a limited liability company. The company was registered in 2010 and has been in the register for 16 years. Registered address: Rīga, Kronvalda bulvāris 3 - 1.
Financial results
Revenue in 2025 was 29 079 €, down 30,2% on the previous year (41 639 €). From 2012 to 2025, revenue grew by an average of 33,9% per year. 2025 ended with a loss of 3265 €. The company was profitable in 3 of the 14 published years. According to the report, the company had no employees in 2025.
Management and owners
The company has one board member. The sole owner of the company is MIP Pharma GmbH.
Points to note
Equity was negative at the end of 2025 (-229 953 €).
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.